Ozempic and Wegovy May Slow Biological Aging
GLP-1 drugs could impact aging processes.
1A New Benefit of GLP-1 Drugs
GLP-1 medications like Ozempic and Wegovy are known for benefits such as weight loss and blood sugar control. A new study suggests these drugs may also slow biological aging. Research on HIV patients showed that semaglutide slows aging by influencing DNA markers.
2Measuring Aging with Epigenetic Clocks
Researchers used epigenetic clocks to measure biological aging. These clocks analyze DNA methylation to determine the rate of cellular aging. In HIV patients, accelerated aging slowed with semaglutide treatment. These findings suggest similar effects could apply to the general population.
3Inflammation and Metabolic Health
GLP-1 drugs slow aging by reducing inflammation and improving metabolic health. They particularly decrease fat accumulation around internal organs, blocking signals that accelerate aging. These mechanisms explain the drug’s impact on aging.
4Promising Results in HIV Patients
In patients with HIV-associated lipohypertrophy, semaglutide treatment slowed the rate of biological aging. According to the DunedinPACE clock, aging slowed by 9%. These findings indicate the drug’s potential to influence aging processes.
5Applicable to the General Population?
Researchers note that the findings could extend beyond HIV patients. Aging processes function similarly in the general population. Therefore, GLP-1 drugs may have the potential to extend healthspan for a broader audience.
6Future Research and Applications
Scientists emphasize that semaglutide does not reverse aging but may slow the process. Larger clinical trials are needed to confirm results and develop effective treatment plans. Personalized treatments using epigenetic clocks could better manage aging processes.